Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (11-20 of 312) with videos related to

Pageof 32
Sort By:
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: CommentaryNeal D Shore
Reviews in Urology|May 26, 2016
LUGPA Welcomes Membership of Smaller PracticesNeal D Shore
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancerNeal D Shore
Urology|November 9, 2010
Editorial comment. Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostateNeal D Shore
Reviews in Urology|February 24, 2018
Are You Developing an ABC: Advanced Bladder Cancer Clinic?Neal D Shore
Immunotherapy|April 26, 2014
PROSTVAC® targeted immunotherapy candidate for prostate cancerNeal D Shore
Oncology (Williston Park, N.Y.)|March 1, 2014
The success of therapies for metastatic CRPC continuesNeal D Shore
BJU International|March 12, 2014
Advances in the understanding of cancer immunotherapyNeal D Shore
Urology|February 16, 2015
Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspectiveNeal D Shore
Therapeutic Advances in Urology|February 2, 2013
Experience with degarelix in the treatment of prostate cancerNeal D Shore
Pageof 32

Showing results (11-20 of 312) with videos related to

Sort By:
Pageof 32
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: CommentaryNeal D Shore
Reviews in Urology|May 26, 2016
LUGPA Welcomes Membership of Smaller PracticesNeal D Shore
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancerNeal D Shore
Urology|November 9, 2010
Editorial comment. Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostateNeal D Shore
Reviews in Urology|February 24, 2018
Are You Developing an ABC: Advanced Bladder Cancer Clinic?Neal D Shore
Immunotherapy|April 26, 2014
PROSTVAC® targeted immunotherapy candidate for prostate cancerNeal D Shore
Oncology (Williston Park, N.Y.)|March 1, 2014
The success of therapies for metastatic CRPC continuesNeal D Shore
BJU International|March 12, 2014
Advances in the understanding of cancer immunotherapyNeal D Shore
Urology|February 16, 2015
Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspectiveNeal D Shore
Therapeutic Advances in Urology|February 2, 2013
Experience with degarelix in the treatment of prostate cancerNeal D Shore
Pageof 32